Reaktionsgleichung
C(OC(N1CC(O[CH:14]([F:16])[F:15])CC1C1NC(C2C=CC(Br)=CC=2)=CN=1)=O)(C)(C)C.C(OC(N1CC(O)CC1C1NC(C2C=CC(Br)=CC=2)=CN=1)=O)(C)(C)C.[C:54]([O:58][C:59]([N:61]1[CH2:65][CH:64]([OH:66])[CH2:63][CH:62]1[C:67]([O:69][CH2:70][C:71]([C:73]1[CH:78]=[CH:77][C:76]([Br:79])=[CH:75][CH:74]=1)=[O:72])=[O:68])=[O:60])([CH3:57])([CH3:56])[CH3:55]>>[C:54]([O:58][C:59]([N:61]1[CH2:65][CH:64]([O:66][CH:14]([F:16])[F:15])[CH2:63][CH:62]1[C:67]([O:69][CH2:70][C:71]([C:73]1[CH:78]=[CH:77][C:76]([Br:79])=[CH:75][CH:74]=1)=[O:72])=[O:68])=[O:60])([CH3:57])([CH3:55])[CH3:56]Komponenten
4
Edukt 3
Produkt 1
Versuchsvorschrift
2-[5-(4-Bromo-phenyl)-1H-imidazol-2-yl-4-difluoromethoxy-pyrrolidine-1-carboxylic acid tert-butyl ester: Title compound was prepared according to the method employed to prepare 2-[5-(4-Bromo-phenyl)-1H-imidazol-2-yl]-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (Example 1), substituting 4-Difluoromethoxy-pyrrolidine-1,2-dicarboxylic acid 2-[2-(4-bromo-phenyl)-2-oxo-ethyl]ester 1-tert-butyl ester (305 mg) for 4-Hydroxy-pyrrolidine-1,2-dicarboxylic acid 2-[2-(4-bromo-phenyl)-2-oxo-ethyl]ester 1-tert-butyl ester (244 mg, 83%).
Quellen und Nachweise
- ORD-Eintrag
- ord-7c276dadf63b420ba71bc91ff866dcff
- Quelldatensatz
- uspto-grants-2012_01
- Patentnummer
- US08088368B2
Verknüpfte Notizen
Wird geladen…